Skip to main content
Erschienen in: Osteoporosis International 8/2016

24.03.2016 | Case Report

Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment

verfasst von: A. Monegal, P. Peris, M. Alsina, J. Colmenero, N. Guañabens

Erschienen in: Osteoporosis International | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Non-uremic calciphylaxis is a severe rare disorder characterized by ischemic necrosis. Recently, three cases of cutaneous calciphylaxis have been described in the context of teriparatide treatment. We present a 51-year-old woman with alcoholic cirrhosis who developed multiorganic calciphylaxis shortly after starting teriparatide treatment associated with calcium and 25-hydroxyvitamin D supplements for severe osteoporosis. After lengthy care of the infectious complications and treatment with bisphosphonates and sodium thiosulfate progressive improvement was observed over a 3-year period. The time between the initiation of teriparatide and the development of calciphylaxis suggests that this agent may have been the triggering factor of this process. Nevertheless, other non-negligible risk factors for calciphylaxis such as alcoholic liver disease, obesity, and vitamin D treatment must also be considered in this patient. Considering the severity of this extremely rare clinical condition, better knowledge of the risk factors related to calciphylaxis development is mandatory.
Literatur
1.
Zurück zum Zitat Hayashi M (2013) Calciphylaxis: diagnosis and clinical features. Clin Exp Nephrol 17:498–503CrossRefPubMed Hayashi M (2013) Calciphylaxis: diagnosis and clinical features. Clin Exp Nephrol 17:498–503CrossRefPubMed
2.
Zurück zum Zitat Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM et al (2015) Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis 66:133–146CrossRefPubMedPubMedCentral Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM et al (2015) Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis 66:133–146CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Kim NR, Seo JW, Lim YH, Ham HS, Huh W, Han J (2012) Pulmonary calcphylaxis associated with acute respiratory and renal failure due to cryptogenic hypercalcemia; an autopsy case report. Korean J Pathol 46:601–604CrossRefPubMedPubMedCentral Kim NR, Seo JW, Lim YH, Ham HS, Huh W, Han J (2012) Pulmonary calcphylaxis associated with acute respiratory and renal failure due to cryptogenic hypercalcemia; an autopsy case report. Korean J Pathol 46:601–604CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Weenig RH, Sewell LD, Davis MPD, McCarthy JT, Pittelkow MR (2007) Calciphylaxis: natural history, risk factors analysis and outcome. J Am Acad Dermatol 26:569–579CrossRef Weenig RH, Sewell LD, Davis MPD, McCarthy JT, Pittelkow MR (2007) Calciphylaxis: natural history, risk factors analysis and outcome. J Am Acad Dermatol 26:569–579CrossRef
6.
Zurück zum Zitat Bonchak J, Park KK, Vethanayagamony T, Sheikh MM, Winterfield LS (2015) Calciphylaxis: a case series and the roles of radiology in diagnosis. Int J Dermatol. doi:10.11111/ijd13043 PubMed Bonchak J, Park KK, Vethanayagamony T, Sheikh MM, Winterfield LS (2015) Calciphylaxis: a case series and the roles of radiology in diagnosis. Int J Dermatol. doi:10.​11111/​ijd13043 PubMed
7.
Zurück zum Zitat Leis-Dosil VM, Rubio Flores C, Ruiz-Bravo E, Díaz-Díaz RM (2013) Cuatneous vascular calcification secondary to treatment with teriparatide. Acta Dermosifiliogr 104:87–88CrossRef Leis-Dosil VM, Rubio Flores C, Ruiz-Bravo E, Díaz-Díaz RM (2013) Cuatneous vascular calcification secondary to treatment with teriparatide. Acta Dermosifiliogr 104:87–88CrossRef
8.
Zurück zum Zitat Dominguez AR, Goldman BA (2013) Nonuremic calciphylaxis in a patient with rheumatoid arthritis and osteoporosis treated with teriparatide. J Am Acad Dermatol 70:e41–e42CrossRef Dominguez AR, Goldman BA (2013) Nonuremic calciphylaxis in a patient with rheumatoid arthritis and osteoporosis treated with teriparatide. J Am Acad Dermatol 70:e41–e42CrossRef
9.
Zurück zum Zitat Spanakis EK, Sellmeyer DE (2014) Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1–34)] therapy in the setting of cronic warfarin and glucocorticoid treatment. Osteoporos Int 25:1411–1414CrossRefPubMed Spanakis EK, Sellmeyer DE (2014) Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1–34)] therapy in the setting of cronic warfarin and glucocorticoid treatment. Osteoporos Int 25:1411–1414CrossRefPubMed
10.
Zurück zum Zitat Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S et al (2001) Catabolic effects of continuous human PTH (1–38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinol 142:4047–4054 Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S et al (2001) Catabolic effects of continuous human PTH (1–38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinol 142:4047–4054
11.
12.
Zurück zum Zitat Weenig RH (2008) Pathogenesis of calciphylaxis: Hans Selye to nuclear factor κ-β. J Am Acad Dermatol 58:458–471CrossRefPubMed Weenig RH (2008) Pathogenesis of calciphylaxis: Hans Selye to nuclear factor κ-β. J Am Acad Dermatol 58:458–471CrossRefPubMed
13.
Zurück zum Zitat Mason D, Best SD (2010) Calcific uremic arteriopathy: contemporary pharmacotherapy. Adv Chronic Kidney Dis 17:428–438CrossRefPubMed Mason D, Best SD (2010) Calcific uremic arteriopathy: contemporary pharmacotherapy. Adv Chronic Kidney Dis 17:428–438CrossRefPubMed
14.
Zurück zum Zitat Ross EA (2011) Evolution of treatment strategies for calciphylaxis. Am J Nephrol 34:460–467CrossRefPubMed Ross EA (2011) Evolution of treatment strategies for calciphylaxis. Am J Nephrol 34:460–467CrossRefPubMed
15.
Zurück zum Zitat Torregrosa JV, Duran CE, Barros X, Blasco M, Arias M, Cases A, Campistol JM (2012) Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. Nefrologia 32:329–334PubMed Torregrosa JV, Duran CE, Barros X, Blasco M, Arias M, Cases A, Campistol JM (2012) Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. Nefrologia 32:329–334PubMed
16.
Metadaten
Titel
Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment
verfasst von
A. Monegal
P. Peris
M. Alsina
J. Colmenero
N. Guañabens
Publikationsdatum
24.03.2016
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 8/2016
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3571-1

Weitere Artikel der Ausgabe 8/2016

Osteoporosis International 8/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.